TC BioPharm to Present at LD Micro Invitational XIII Conference on June 7, 2023
LD Micro Invitational XIII Conference
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to develop and commercialize innovative cell-based products and to treat disease, improve patient health and Quality of Life.
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.
TC BioPharm Limited
2 Parklands Way
Holytown, Motherwell ML1 4WR
T: +44 (0) 141 433 7557
Computershare Investor Services PLC